Luxdegalutamide (ARV-766) is a novel, potent, and orally bioavailable proteolytic targeting chimera (PROTAC) protein degrader that degrades not only wild-type AR but also clinically relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.
Molekulargewicht:
807.95
Reinheit:
99.95%
CAS Nummer:
[2750830-09-0]
Formel:
C45H54FN7O6
Target-Kategorie:
PROTACs,Androgen Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten